NASDAQ · Medical - Devices

IRIX (IRIX) Stock

$0.89 -0.22% NASDAQ: IRIX Healthcare

Valuation

MetricValue
Price$0.89
Market Cap$15.47M
P/E Ratio-3.85
P/B Ratio3.48
P/S Ratio0.33
EPS (TTM)$-0.26
52-Week High$1.65
52-Week Low$0.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-80.00%
ROA-13.79%
ROCE-60.00%
Gross Margin-3.77%
Operating Margin-5.66%
Net Margin-6.23%
Debt/Equity0.11
Current Ratio1.92

Annual Financials (USD)

Metric20212022202320242025
Revenue$54.0M$57.0M$52.0M$49.0M$53.0M
Operating Profit$-8.0M$-8.0M$-10.0M$-8.0M$-3.0M
Net Profit$-5.0M$-8.0M$-10.0M$-9.0M$-4.0M
EPS$-0.34$-0.47$-0.59$-0.54$-0.26
Op Margin-14.0%-13.2%-19.3%-17.1%-4.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$49.0M$42.0M$34.0M$29.0M$29.0M
Total Liabilities$25.0M$25.0M$25.0M$27.0M$24.0M
Cash$24.0M$14.0M$7.0M$2.0M$6.0M
Borrowings$3.0M$2.0M$3.0M$5.0M$5.0M

Latest News

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering GlobeNewswire · Jul 20, 2026 Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference GlobeNewswire · Jun 9, 2026 IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth Zacks · May 25, 2026 IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... GuruFocus.com · May 20, 2026 IRIDEX Corporation Q1 2026 Earnings Call Summary Moby · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$8.0M$-10.0M$-7.0M$-7.0M$-2.0M
Investing Cash Flow$-6.0M$-1.0M$0$0$0
Financing Cash Flow$0$0$0$-1.0M$0
Net Cash Flow$12.0M$-10.0M$-7.0M$-5.0M$4.0M
Free Cash Flow$8.0M$-10.0M$-7.0M$-7.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-13.51%
Quick Ratio1.19
Interest Coverage—
Return 1Y5.00%
Return 3Y-47.50%
Return 5Y-83.31%

Ownership

Insiders Held37.07%
Institutions Held18.04%
Institutions Float Held28.66%
Institutional HolderSharesReport Date
Paragon Associates & Paragon Associates Ii Joint Venture1,000,0002026-03-31
Vanguard Capital Management LLC514,5932026-03-31
Renaissance Technologies, LLC396,6272026-03-31
Weber Capital Management LLC /ADV259,5582026-03-31
Geode Capital Management, LLC160,1592026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADGM $0.38 +1.60% -0.56 $8.45M 0.00%
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
ASBP $7.26 +3.13% -0.74 $837601 0.00%
COCH $0.67 +1.71% -0.74 $14.02M 0.00%
HOTH $1.13 -23.65% -0.70 $14.92M 0.00%

About IRIX

IRIX is led by CEO Patrick Mercer, employs 93 people, headquartered in US, publicly traded since 1996.

IRIX stock trades at $0.89 with a market capitalization of $15.47M. The stock is valued at a price-to-earnings (P/E) ratio of -3.85, price-to-book of 3.48, price-to-sales of 0.33. Over the past 52 weeks the stock has ranged between $0.87 and $1.65, and currently trades 46.1% below its 52-week high.

On profitability, IRIX generates a return on equity (ROE) of -80.00%, return on capital employed of -60.00%, an operating margin of -5.66%, a net profit margin of -6.23%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides